MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
13.80
+0.19 (1.40%)
Nov 26, 2025, 4:00 PM EST - Market closed

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
350.74180.43451.1739.518.04
Short-Term Investments
29.74267.659.8432.61-
Cash & Short-Term Investments
380.48448.03511.0172.118.04
Cash Growth
-22.97%-12.32%608.60%797.08%-
Other Receivables
4.022.841.060.220.15
Receivables
4.022.841.060.220.15
Prepaid Expenses
26.7123.422.14.181.45
Total Current Assets
411.22474.29514.1776.519.64
Property, Plant & Equipment
2.533.643.950.330.05
Other Long-Term Assets
--8.42--
Total Assets
414.34477.93526.5476.849.68
Accounts Payable
0.650.220.330.160.03
Accrued Expenses
45.220.238.077.244.76
Short-Term Debt
----15
Current Portion of Leases
1.51.371.20.15-
Current Income Taxes Payable
1.010.640.370.110.06
Other Current Liabilities
----1.23
Total Current Liabilities
48.3722.469.977.6721.09
Long-Term Leases
0.491.462.50.13-
Pension & Post-Retirement Benefits
0.550.620.580.280.24
Total Liabilities
123.1424.5413.058.0821.33
Common Stock
0.010.010.010.010.04
Additional Paid-In Capital
689.11677.41609.97129.1942.06
Retained Earnings
-400.49-235.59-116.66-80.65-53.64
Treasury Stock
-----0.01
Comprehensive Income & Other
0.2852.360.35-0.17
Total Common Equity
288.91446.83495.6848.9-11.72
Minority Interest
2.296.5717.8219.87-
Shareholders' Equity
291.19453.39513.4968.77-11.65
Total Liabilities & Equity
414.34477.93526.5476.849.68
Total Debt
75.732.833.70.2815
Net Cash (Debt)
304.75445.2507.3171.83-6.96
Net Cash Growth
-37.87%-12.24%606.24%--
Net Cash Per Share
4.827.0810.332.45-0.89
Filing Date Shares Outstanding
63.763.2862.8739.150.3
Total Common Shares Outstanding
63.763.0860.4738.980.3
Working Capital
362.85451.82504.268.85-11.45
Book Value Per Share
4.547.088.201.25-38.57
Tangible Book Value
288.91446.83495.6848.9-11.72
Tangible Book Value Per Share
4.547.088.201.25-38.57
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q